Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kuanxiong aerosol for relief of angina in coronary heart disease
ChiCTR-IPR-15007204Phase 4Completed
- Sponsor
- Xiyuan Hospital
- Start
- Nov 2011
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of kuanxiong aerosol in coronary arteriosclerosis and angina pectoris (2 arms), sponsored by Xiyuan Hospital. Primary endpoint: Relief time of angina pectoris. Started Nov 2011; status: completed.
02
Drugs
kuanxiong aerosol
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on ChiCTR-IPR-15007204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007204.